Growing Incidence of Malignant Mesothelioma and Its Treatment To Be Addressed at International Investigators' Meeting: Germany, Italy, Israel and the Czech Republic Participating in Alfacell's MM Program
Press Release from Alfacell, April 15, 2002

Orphan Drug Designation Granted for Treatment of Mesothelioma and Ovarian Cancer
Press Release from NeoPharm, Inc., February 14, 2002

Study Shows SuperGen's Decitabine Corrects DNA Methylation, Key Mechanism of Cancer Growth: Data presented at 93rd Annual Meeting of AACR
Press Release from SuperGen, April 11, 2002

Update on Phase III Program of ONCONASE � for The Treatment of Patients with Unresectable Malignant Mesothelioma
Press Release from Alfacell, April 3, 2002

New anti-cancer drug to be trialed on humans
Report from ABC News, April 2002

Encouraging Survival in Patients With Advanced Malignant Mesothelioma Treated With Alfacell's ONCONASE �
Press Release from Alfacell, January 22, 2002

In the company of asbestos Magic mineral to killer dust: Turner & Newall and the asbestos hazard
Geoffrey Tweedale. Oxford: Oxford University Press, 2000.
Pp 334. �40�00. ISBN 0198296908.

Entremed, Inc. Releases Endostatin Phase I Study Data
November 9, 2000

A Review of Dr. Sugarbaker's Results Using Tri-Modal Therapy on 183 Patients from 1980 to 1997

Current Therapy for Mesothelioma, Sugarbaker, et al, 1997

Mesothelioma, current insights (1994)

Successful Immunochemotherapy for Patients with Malignant Mesothelioma: Report of Two Cases

Multimodality Management of Malignant Pleural Mesothelioma

Familial Pleural Malignant Mesothelioma: Clustering in Three Sisters and One Cousin

Malignant Mesothelioma in Women

Pathology of Diffuse Malignant Pleural Mesothelioma

Primary Immunochemotherapy for Malignant Pleural Mesothelioma

Reactive Mesothelial Hyperplasia vs. Mesothelioma, Including Mesothelioma in Situ: a Brief Review

"Idiopathic" Mesotheliomas Questioned: Is there such a thing as "background" level asbestos exposures?

Abstracts found in various medical journals which address Treatment Options for Mesothelioma Patients (1991-1995):

Mesothelioma and radical multimodality therapy: who benefits? [Review]

Curative resection of a well-differentiated papillary mesothelioma of the pericardium.

Trials in malignant mesothelioma. LCSG 851 and 882. [Review]

Operation and intracavitary photodynamic therapy for malignant pleural mesothelioma: a phase II study.

Prognostic factors and survival in malignant pleural mesothelioma.

Malignant pleural mesothelioma. Extrapleural pneumonectomy and pleurectomy. [Review]

A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.

Prognostic factors of malignant mesothelioma of the pleura.

Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients.

Pleurectomy/decortication and adjuvant therapy for malignant mesothelioma.

Extrapleural pneumonectomy in the setting of a multimodality approach to malignant mesothelioma.

Survival of asbestos insulation workers with mesothelioma.

Diagnostic and therapeutic strategy in malignant pleural mesothelioma.

Extrapleural pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma.

The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial.

Pleurectomy for mesothelioma.

Abstracts Found in Various Medical Journals Concerning Peritoneal Mesothelioma:

Peritoneal mesothelioma in a 17-year-old boy with evidence of previous exposure to chrysotile and tremolite asbestos.

Intraperitoneal cisplatin and etoposide in peritoneal mesothelioma: favorable outcome with a multimodality approach.

Intestinal obstruction due to diffuse peritoneal fibrosis at 2 years after the successful treatment of malignant peritoneal mesothelioma with intraperitoneal mitoxantrone.

Malignant peritoneal mesothelioma in childhood with long-term survival.

Successful therapy of peritoneal mesothelioma with intraperitoneal chemotherapy alone. A case report.

Intraperitoneal chemotherapy for malignant peritoneal mesothelioma.

Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma.

Death certificate categorization of malignant pleural and peritoneal mesothelioma in a cohort of asbestos insulation workers.

Asbestos, laryngeal carcinoma, and malignant peritoneal mesothelioma in an insulation worker.

Articles That Discuss Treatment and Results in Certain Case Studies:

Serologic responses in patients with malignant mesothelioma: evidence for both public and private specificities.

Brain metastasis from malignant mesothelioma--case report.

Taxol inhibits growth of mesothelioma xenografts.

Combined chemotherapy in pleurectomized malignant pleural mesothelioma patients.

A phase II trial investigating primary immunochemotherapy for malignant pleural mesothelioma and the feasibility of adjuvant immunochemotherapy after maximal cytoreduction.

Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma: the UCLA experience.

Treatment of malignant mesothelioma with methotrexate and vinblastine, with or without platinum chemotherapy.

Malignant mesothelioma and duration of asbestos exposure: correlation with tissue mineral fibre content.

Mesothelioma as a risk indicator of asbestos exposure: the role of the pathologist.

Clinical course of human epithelial-type malignant pleural mesothelioma replicated in an orthotopic-transplant nude mouse model.

Malignant mesothelioma associated with low pulmonary tissue asbestos burdens: a light and scanning electron microscopic analysis of 18 cases.

Articles that Discuss Causation, Diagnosis and Risk Factors:

Continuing increase in mesothelioma mortality in Britain.

Dietary Intake and the Risk of Malignant Mesothelioma (Beta Carotene Reduces Meso Risk!).

Pleural mesotheliomas are underreported as occupational cancer in Sweden.

Pleural Plaques and Risk for Bronchial Carcinoma and Mesothelioma. A prospective study.

Mesothelioma: is asbestos exposure the only cause?

Malignant mesothelioma associated with low pulmonary tissue asbestos burdens: a light and scanning electron microscopic analysis of 18 cases.

Aspects of histopathologic subtype as a prognostic factor in 85 pleural mesotheliomas.

Malignant pleural mesothelioma caused by environmental exposure to asbestos or erionite in rural Turkey: CT findings in 84 patients.

Asbestos fiber type in malignant mesothelioma: an analytical scanning electron microscopic study of 94 cases.

Malignant mesothelioma in women.

Concurrent mesothelioma and adenocarcinoma of the lung in a patient with asbestosis.

Reactive Mesothelial Hyperplasia vs Mesothelioma, Including Mesothelioma in Situ: a Brief Review.

"Idiopathic" Mesotheliomas Questioned: Is there such a thing as "background" level asbestos exposures?

Resources

The following are links to other informative web sites, as well as resource information that may be useful to those seeking to learn more about mesothelioma, lung cancer, asbestosis and other asbestos-related diseases.

CancerWEB
Published by the National Cancer Institute, this site provides information about many types of cancer, including all types of mesothelioma, in addition to information about treatment protocols.

PubMed
This site is published by the National Library of Medicine, and contains a search engine with access to 9 million MedLine and pre-MedLine citations allowing you to search for articles on mesothelioma by keyword.

OncoLink
Published by the University of Pennsylvania Cancer Center, this site provides a number of resources for mesothelioma, including its treatment.

CancerNet
Published by the National Cancer Institute, this site provides the latest information about cancer and cancer treatment for use by patients and physicians alike.

CancerHelp
This site provides a number of links to other cancer information sites on the internet and to cancer support groups.

Lung Cancer Information Center
Presented by Medicine On Line, this site provides useful information on cancer, including mesothelioma, as well as links to other resources, and an 800 number to call for more information.

Clinical Trials for Mestothelioma
This site, presented by CenterWatch Clinical Trials Listing Service, provides a comprehensive list of clinical trials. Its database is searchable by keyword.

National Center for Biotechnology Information
This site contains a database and research information on biotechnology issues.

American Journal of Respiratory and Critical Care Medicine
Allows you to search for articles on a variety of topics using keywords.

Division of Thoracic Surgery at Brigham & Women's Hospital
Presented by the Division of Thoracic Surgery in Boston, Massachusetts, this site provides information about cancer, the treatments available at their facilities, and making appointments.

Memorial Sloan-Kettering Cancer and Treatment Information
Presented by Memorial Sloan-Kettering Hospital in New York, this site provides some basic information on lung cancer, with links to support group information.

University of Pittsburgh Comprehensive Lung Center
Information about UPMC's Comprehensive Lung Center, and links to other sites.

H. Lee Moffitt Cancer Center & Research Institute
The web site of this Tampa, Florida hospital has information on cancer issues, and allows you to make appointments on-line.

U.S. Naval and Shipbuilding Museum
This site is a great resource for information on U.S. military ships, links to associated organizations throughout the world, and general information on the shipbuilding industry. Also included on the site is the Dictionary of American Naval Fighting Ships. The U.S.S. Salem (CA-139) is a World War II era heavy cruiser that has been converted into a floating museum at the Fore River Shipyard just outside of Boston in Quincy, Massachusetts.

Click here for More Resources

Click here for Books on Mesothelioma